Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Is anyone still following this one? I'm pretty new to valuation and I know biotechs are tricky anyway, but would anyone like to take a crack at it? The price has gone up quite a bit in the last few months.
Print the post Back To Top
No. of Recommendations: 0
ya, tell me about it, I started buying last April and have seen over 100% returns. There is potential for greater growth, but the big discount is about over. I think it is fairly valued now, FWIW.
Print the post Back To Top
No. of Recommendations: 0
Yeah, on yahoo finance I was reading that institutions have control over virtually all the float... so it probably isn't a "hidden gem" candidate any more. I'll be watching closely, and hopefully getting more practice at valuation in the meantime. Thanks for the reply.
Print the post Back To Top
No. of Recommendations: 0
I concur that ILMN is fully valued at this point (as compared to, say, AFFX, which is a competitor and has dropped quite a bit recently). Still seems to be a quality outfit worth tracking, though.

Rumor on another board has it that there is legal action between those two. Any knowledge?

jp
Print the post Back To Top